MarketsFN
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
Stocks

Docusign (DOCU) Q2 2027 Financial Results Summary

QuoteReporter

4 min read
Docusign (DOCU) Q2 2027 Financial Results Summary

Docusign, Inc. (DOCU) Q2 2027: Revenue Growth and Increased Guidance — Positive Outlook

Docusign, Inc. (NASDAQ: DOCU) reported its second fiscal quarter results for the period ending July 31, 2026, revealing a revenue of $875.7 million, which represents a $75.1 million or +9% increase year-over-year. This growth is notable as it includes a foreign exchange benefit of approximately 1.3%.

Overall, this quarter can be viewed positively for shareholders. The revenue growth, coupled with improvements in net income and cash flow metrics, indicates a strengthening business performance. The company also raised its fiscal year 2027 guidance, reflecting confidence in its growth trajectory.

Key Financial Metrics:

  • Revenue: $875.7 million, up $75.1 million or +9% YoY
  • GAAP Net Income:
    • Basic EPS: $0.41 (up from $0.31 YoY)
    • Diluted EPS: $0.40 (up from $0.30 YoY)
  • Non-GAAP Net Income per Diluted Share: $1.16 (up from $0.92 YoY)
  • Free Cash Flow: $295.8 million, or a 34% margin, compared to $217.6 million, or 27% margin, in the same period last year.
  • Net Cash Provided by Operating Activities: $334.5 million, up from $246.1 million YoY.
  • Repurchases of Common Stock: $306.5 million, compared to $201.5 million in the same period last year.

Business Highlights:

  • Intelligent Agreement Management (IAM): Represented 15.1% of total Annual Recurring Revenue (ARR) as of July 31, 2026, up from 12.6% as of April 30, 2026.
  • Gross Margin: GAAP gross margin was 79.7%, compared to 79.3% in the same period last year. Non-GAAP gross margin was 81.7%, down from 82.0% YoY.

Guidance Update:

Docusign has increased its fiscal year 2027 guidance:

  • Revenue Guidance: $3,499 million to $3,507 million, reflecting a 9% year-over-year growth.
  • Non-GAAP Gross Margin Guidance: 81.5% to 82.0%.
  • Annual Recurring Revenue Growth Rate: Expected to be 8.50% to 9.00%.

Analyst Opinion:

This quarter's results are encouraging for shareholders, showcasing a solid revenue increase and improved profitability metrics. The increase in guidance suggests that Docusign is well-positioned to capitalize on the growing demand for its services, particularly in the realm of AI-driven solutions. The company's focus on enhancing its IAM capabilities and integrating AI into its offerings is likely to drive further growth.

Forward Catalyst:

Investors should closely monitor Docusign's performance in the upcoming quarter, particularly the adoption rates of its IAM solutions and the impact of AI on its business operations. Additionally, any updates on customer acquisition and retention strategies will be crucial as the company aims to expand its market share in the digital agreement space.

Here are the extracted tables:

Note: All amounts in the following tables are in thousands.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

Three Months Ended Six Months Ended
July 31, 2026 July 31, 2025 July 31, 2026 July 31, 2025
Revenue $ 875,746 $ 800,636 $ 1,705,… $ 1,564,2…
Cost of revenue 177,872 165,463 349,142 322,732
Gross profit 697,874 635,173 1,356,… 1,241,5…
Operating expenses
Sales and marketing 313,958 305,450 610,133 601,863
Research and development 163,582 169,630 323,168 329,077
General and administrative 102,713 94,866 194,608 185,136
Total operating expenses 580,253 569,946 1,127,… 1,116,0…
Income from operations 117,621 65,227 228,930 125,482
Interest expense -569 -828 -1,120 -1,306
Interest income and other income, net 7,924 12,061 14,922 26,074
Income before provision for income taxes 124,976 76,460 242,732 150,250
Provision for income taxes 47,261 13,490 86,820 15,193
Net income $ 77,715 $ 62,970 $ 155,912 $ 135,057
Net income per share attributable to common stock:
Basic $ 0.41 $ 0.31 $ 0.81 $ 0.67
Diluted $ 0.40 $ 0.30 $ 0.80 $ 0.64
Weighted-average shares used to compute net income per share:
Basic 191,252 202,644 193,336 202,957
Diluted 193,117 210,956 194,763 211,878
Stock-based compensation expense included in costs and expenses
Cost of revenue $ 15,241 $ 18,592 $ 30,550 $ 35,496
Sales and marketing 46,828 49,081 89,854 95,166
Research and development 55,502 61,865 109,978 116,296
General and administrative 31,033 31,000 59,599 59,176

CONDENSED CONSOLIDATED BALANCE SHEETS

July 31, 2026 January 31, 2026
Assets
Current assets
Cash and cash equivalents $ 528,161 $ 602,442
Investments—current 249,516 264,084
Accounts receivable, net 370,531 516,429
Contract assets—current 7,552 10,782
Prepaid expenses and other current assets 113,132 97,101
Total current assets 1,268,892 1,490,838
Investments—noncurrent 195,398 208,393
Property and equipment, net 420,032 361,808
Operating lease right-of-use assets 155,101 165,578
Goodwill 458,365 458,446
Intangible assets, net 51,924 61,394
Deferred contract acquisition costs—noncurrent 468,812 474,628
Deferred tax assets—noncurrent 764,330 835,245
Other assets—noncurrent 177,936 173,220
Total assets $ 3,960,790 $ 4,229,550
Liabilities and Equity
Current liabilities
Accounts payable $ 21,866 $ 17,419
Accrued expenses and other current liabilities 121,046 113,358
Accrued compensation 239,042 260,840
Contract liabilities—current 1,575,565 1,631,168
Operating lease liabilities—current 15,516 16,623
Total current liabilities 1,973,035 2,039,408
Contract liabilities—noncurrent 28,824 29,956
Operating lease liabilities—noncurrent 167,582 168,496
Deferred tax liability—noncurrent 20,960 21,507
Other liabilities—noncurrent 51,869 52,363
Total liabilities 2,242,270 2,311,730
Stockholders’ equity
Common stock 19 20
Additional paid-in capital 4,052,431 3,777,995
Accumulated other comprehensive loss -7,843 -3,712
Accumulated deficit -2,326,087 -1,856,483
Total stockholders’ equity 1,718,520 1,917,820
Total liabilities and equity $ 3,960,790 $ 4,229,550

Disclaimer

The content on MarketsFN.com is provided for educational and informational purposes only. It does not constitute financial advice, investment recommendations, or trading guidance. All investments carry risk and past performance does not guarantee future results. You are solely responsible for your investment decisions and should conduct independent research and consult a qualified financial advisor before acting. MarketsFN.com and its authors are not liable for any losses or damages arising from the use of this information.

Related Articles

Ambarella (AMBA) AMBA Q2 Financial Results Summary
Trending
Stocks

Ambarella (AMBA) AMBA Q2 Financial Results Summary

QuoteReporter
3 minSep 4, 2026
Planet Labs PBC (PL) Q2 2027 Financial Results Summary
Trending
Stocks

Planet Labs PBC (PL) Q2 2027 Financial Results Summary

QuoteReporter
4 minSep 4, 2026
UiPath (PATH) quarter year
UiPath Financial Results Summary
Trending
Stocks

UiPath (PATH) quarter year UiPath Financial Results Summary

QuoteReporter
4 minSep 4, 2026